WIRKUNG JOHNSON UND JOHNSON

Skip to inhalt
*
Home link (shasheelamotors.com Logo)
*
Home link (shasheelamotors.com Logo)
*
Home verknüpfung (shasheelamotors.com Logo)
*
Home verknüpfung (shasheelamotors.com Logo)
food selection Search Toggle menu
*
readjust Country
*
*

This site is governed solely by applicable U.S. Laws and governmental regulations. Please seen our Privacy Policy. Use von this website constitutes her consent zu application des such laws und regulations and to ours Privacy Policy. Her use von the information on this site is subject to the terms of our legit Notice. You should see the nachrichten section and the most recent SEC Filings in the investor section in order to receive the most current die info made available über Johnson & johnson Services, Inc. Call Us with any questions or find this site weil das more information. Do notfall Sell My mitarbeiter Information


Close countries Menu
Explore more johnson & johnson sites:
Australia
*
alt
Argentina
*
alt
Brazil
*
alt
Canada
*
alt
Chile
*
alt
china
*
alt
Colombia
*
alt
Costa Rica
*
alt
Czech Republic
ecuador
*
alt
Germany
*
alt
India
*
alt
japan
*
alt
Mexico
*
alt
new Zealand / Pacific
*
alt
Paraguay
*
alt
Peru
*
alt
Philippines
*
alt
Russia
*
alt
Switzerland
*
alt
German
English
French
vereinigt Kingdom
*
alt
blume States
*
alt
Uruguay
*
alt
venezuela
*
alt
nearby Search menu
find input
Johnson & johnson Announces Plans zu Separate consumer Health Business
Learn more
Our agency
Johnson & johnson Announces Plans zu Accelerate Innovation, offer Patients and Consumers, and Unlock Value through Intent kommen sie Separate consumer Health Business
Johnson & johnson Announces Plans to Accelerate Innovation, serve Patients and Consumers, and Unlock Value with Intent zu Separate customer Health Business
New consumer Health company would be a global Leader with Iconic Brands und Products the Touch over One Billion lebt Every Day
Johnson & johnson would remain a global Leader bei Healthcare, focused on significant Unmet clinical Needs und Materially advancing Standard des Care through Biopharmaceutical und Medical device Innovation and Technology
Separation Designed to Enhance operational Performance und Strategic Flexibility, services Patients and Consumers and Unlocking Value zum All Stakeholders
New consumer Health company Expected kommen sie Complete Separation in 18 to 24 Months
Johnson & johnson to organize Investor Conference Call heute at 8:30 a.m. ET

NEW BRUNSWICK, N.J. November 12, 2021– johnson & johnson (the “Company”) (NYSE: shasheelamotors.com) heute announced that is intent zu separate ns Company’s customer Health business, developing a new publicly traded company. Ns planned separation would develop two global leaders the are much better positioned kommen sie deliver improved health outcomes for patients und consumers with innovation, pursue much more targeted unternehmen strategies und accelerate growth.

Following the planned separation, the new johnson & johnson would remain die world’s largest und most diverse healthcare company and continue its commitment zu lead an global medical care R&D und innovation, with a portfolio that blends its strong Pharmaceutical and Medical machine capabilities focused on advancing die standard von care through innovation and technology. As previously announced, Mr. Alex Gorsky wollen serve as Executive Chairman of johnson & Johnson und transition ns Chief executive, management Officer role kommen sie Mr. Joaquin Duato, right now Vice Chairman des the Company’s executive Committee, effective januar 3, 2022. Mr. Duato would continue kommen sie lead die new johnson & johnson following completion von the to plan separation.

Du schaust: Wirkung johnson und johnson

Mr. Gorsky said, “Throughout ours storied history, johnson & johnson has demonstrated that we tun können deliver outcomes that benefit all ours stakeholders, and we need to continually be evolving our business to provide value today, tomorrow and an the years ahead. Adhering to a comprehensive review, the Board und management team glauben that the planned separation des the customer Health unternehmen is the best way kommen sie accelerate our efforts zu serve patients, consumers, und healthcare professionals, produce opportunities zum our talented global team, drive profitable growth, und – most importantly – improve health care outcomes for people around the world.”

Mr. Gorsky continued, “For die new johnson & Johnson, this planned separation underscores our focus on transporting industry-leading biopharmaceutical und medical device innovation und technology with die goal des bringing neu solutions to market weil das patients und healthcare systems, while producing sustainable value weil das shareholders. We believe that the new Consumer Health company would be a globalen leader across attractive und growing consumer health categories, and a streamlined und targeted corporate framework would administer it with die agility and flexibility zu grow its above portfolio von brands and innovate neu products. We room committed to die success des each organization, and also our company’s an ext than 136,000 employees around ns globe, who will remain the backbone von these businesses.”

Mr. Duato commented, “This plan transaction would develop two businesses that are each financially strong and leaders bei their particular industries. We believe that die new johnson & Johnson and the neu Consumer Health firm would every be able zu more successfully allocate resources to deliver zum patients und consumers, drive growth and unlock far-reaching value. Importantly, die new johnson & Johnson and the new Consumer Health firm would remain mission driven providers with exceptional brands, commitments to innovation, und remarkable talent. Each company would lug on the johnson & johnson legacy des putting the needs and well-being of the people we offer first.”

The to plan separation ist expected zu create value for all stakeholders von aiming to achieve die following an essential goals:

Increase management focus, resources, agility and speed kommen sie effectively address differing industry trends and to better meet die needs von the new johnson & Johnson and the neu Consumer Health agency patients und consumers;Further focus capital allocation based on die objectives of each elevation company;Provide each agency with a compelling financial profile that much more accurately reflects die strengths und opportunities von each unternehmen and, as a result, supplies investors a more targeted invest opportunity; und Align corporate and operational structures so each company zu sein better able kommen sie drive growth and value creation.

New johnson & Johnson: an Innovative Pharmaceuticals und Medical tools Leader with Sharpened emphasis on major Unmet medical Needs and Advancing Standard of Care weil das Patients Around die WorldFollowing ns planned separation, die new johnson & johnson would remain ns world’s largest und most diverse healthcare company und maintain a portfolio that blends its strong Pharmaceutical und Medical machine capabilities focused on materially advancing die standard des care v biopharmaceutical und medical machine innovation und technology. Leveraging that long-standing strength in core areas des science, technology, regulatory, supply chain und global advertising reach, the new johnson & johnson would continue kommen sie build on its offering von life-saving treatments, consisting of DARZALEX, ERLEADA, IMBRUVICA, STELARA and TREMFYA, and also medical device solutions throughout interventional solutions, orthopaedics, surgery und vision.

The new johnson & johnson would remain committed to changing die trajectory von human health. Die Pharmaceutical und Medical devices segments, which room expected zu generate revenue of approximately $77 billion in Full-Year 2021<1>, room united by their shared und complementary focus on scientific research and development zu serve similar ende users – patients und healthcare service providers – and operate an similar regulatory und competitive environments. Ns new johnson & Johnson is expected zu be better positioned kommen sie combine skills, expertise and approaches zu bring integrated, comprehensive and more impactful care zu patients, addressing diseases an areas such as oncology and eye health that need a combination of surgical, interventional and pharmaceutical treatments. Ns new johnson & johnson would continue kommen sie play a top role in advancing the industry forward von creating novel solutions, bringing together treatments extending therapeutics, robotics, artificial intelligence und more, kommen sie change die way illness are prevented, intercepted und eventually cured.

The Pharmaceutical business would continue to generate sustained over market growth by advancing its solid portfolio and pipeline von products, accelerating an essential therapeutic areas, such together oncology and immunology, while deshalb advancing neu therapeutic modalities such as cell und gene therapies. At the same time, ns Medical Devices unternehmen would plan kommen sie accelerate its momentum throughout orthopaedics, interventional solutions, surgery und vision, with bei increased cadence des meaningful innovation enabled von a strong digital surgical procedure pipeline and focus on execution throughout all geographies.

The new johnson & johnson would remain committed kommen sie maintaining a solid balance sheet und to that is stated capital allocation priorities von R&D investment, compete dividends und value-creating acquisitions.

New customer Health company Post-Separation: A Leading globalen Consumer Health firm with iconic Brands und Commitment to Continued creation The neu Consumer Health agency would it is in a globalen leader through a an effective portfolio von iconic brands — comprising four $1 billion megabrands und 20 brands end $150 million — and leading positions an Self care (OTC), Skin Health and Essential Health, which has baby care, feminine care, wound care and oral health. Die Consumer wellness segment is expected kommen sie generate revenue of approximately $15 billion an Full-Year 2021<2> and, following die planned separation, the neu Consumer Health firm would generate sales an over 100 countries, driven by world-class invention capabilities and demonstrated business momentum.

In recent years, johnson & johnson has focused die Consumer health and wellness business and advanced that innovation, permitting it to reach more consumers with products that truly make a difference in peoples’ lives, when simultaneously broadening margins and delivering gesund financial results. This actions oase bolstered positions in Self Care, Skin Health und Essential Health.

The neu Consumer Health firm would it is in expected zu benefit from a solid investment great profile and balance sheet that would allow it to build on its long history of innovation und maintain und extend that is leadership position across important und growing categories.

The planned organizational entwurf for the neu Consumer health Company zu sein expected zu be completed über the end of 2022 and will it is in subject kommen sie legal requirements consisting of consultation v works councils und employee representatives, as required. Planned neu Consumer Health agency employees space expected kommen sie continue participating in their current johnson & johnson pay, benefits and retirement programs v the ende of 2022.

Mehr sehen: Stiftung Alfred Wegener Institut Bremerhaven, Alfred Wegener Institute

Transaction DetailsThe Board des Directors’ intent zu sein to effect the planned separation through die capital markets, producing two independent, market-leading companies. Die transaction ist intended kommen sie qualify together a tax-free separation for U.S. Federal revenue tax purposes.

In addition, it ist expected that ns overall shareholder dividend wollen remain weist least at the same level following die completion of the transaction.

The Company zu sein targeting completion des the planned separation bei 18 kommen sie 24 months, subject to ns satisfaction des certain conditions including, amongst others, consultations through works councils and other employee representative bodies, together required, last approval of johnson & Johnson’s Board von Directors, receipt des a favorable opinion and Internal Revenue service ruling through respect to ns tax-free nature of ns transaction, and the receipt von other regulation approvals. There tun können be no assurance regarding die ultimate timing des the propose transaction or that the transaction möchte be completed.

Mehr sehen: Wird Er Sich Melden Orakel ? 100% Ja? Orakel: Wann Meldet Er Sich Wieder

AdvisorsGoldman Sachs & Co. LLC and J.P. Morgan Securities LLC are acting together financial torture to johnson & Johnson, und Cravath, Swaine & Moore LLP und Baker & McKenzie LLP room acting together legal counsel.

Investor Conference call The company plans kommen sie hold bei investor webcast zu discuss this announcement und provide opportunity weil das Q&A heute at 8:30 a.m. ET. Die call möchte be hosted von Mr. Joseph Wolk, chief Financial Officer, Mr. Alex Gorsky, Chairman and CEO, and Mr. Joaquin Duato, angry Chairman des the executive Committee. Die webcast ist accessible punkt www.investor.shasheelamotors.com and telephone, zum both “listen-only” participants und financial analysts who wish to take part bei the question und answer portion of the call. You re welcome dial (877) 869-3847 bei the U.S. And (201) 689-8261 outside von the U.S.

About johnson & JohnsonAt johnson & Johnson, we believe good health is the foundation von vibrant lives, growing communities and forward progress. That’s why zum more 보다 130 years, we have aimed to keep civilization well weist every age und every stage von life. Today, as ns world’s largest und most broadly-based healthcare company, we space committed zu using ours reach und size for good. Us strive to improve access und affordability, create healthier communities, und put a healthy mind, body and environment within reach von everyone, everywhere. We space blending ours heart, science and ingenuity zu profoundly change die trajectory des health weil das humanity. Learn more weist www.shasheelamotors.com. Monitor us punkt